Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04680637 |
|
Recruitment Status :
Terminated
(The trial was terminated prematurely as it met pre-defined criteria for futility at IA3.)
First Posted : December 23, 2020
Last Update Posted : October 4, 2023
|
Sponsor:
Amgen
Information provided by (Responsible Party):
Amgen
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | May 22, 2023 |
| Actual Study Completion Date : | May 22, 2023 |